Form 4: NeuroOne Medical Technologies CEO David Rosa Disposes of Shares to Cover Tax Obligations
SEC Form 4
NeuroOne Medical Technologies CEO David Rosa disposed of 2,239 shares of common stock on February 29, 2024, to cover tax obligations related to equity awards.
Summary
- On February 29, 2024, David A Rosa, CEO and President of NeuroOne Medical Technologies Corp, disposed of 2,239 shares of common stock.
- The transaction was executed at a price of $1.21 per share.
- This disposal was to cover tax obligations.
- Following the transaction, Rosa directly owns 1,186,748 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a transaction to cover tax obligations, which is a routine event.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction is not necessarily indicative of the company's overall performance or future prospects.
Stakeholder Impact
- The disposal of shares by the CEO could have a minor negative impact on shareholder sentiment, although it is a common practice to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Date of transaction: David Rosa disposed of 2,239 shares of common stock. |
| 03/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.